TOCAGEN INC (TOCA)
(Delayed Data from NSDQ)
$10.08 USD
+0.28 (2.86%)
Updated May 3, 2019 04:00 PM ET
After-Market: $10.09 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Forte Biosciences, Inc. [TOCA]
Reports for Purchase
Showing records 1 - 12 ( 12 total )
Company: Forte Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Forte Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Eyes on Toca 5 Update; Encouraging Preliminary Data from Toca 6; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Forte Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Forte Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Toca 5 Final Readout and Initiation of Two Trials by YE; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Forte Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
TOCA 5 to Continue as Planned; Final Results by YE; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Forte Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Phase 3 Toca 5 Interim Analysis Imminent and Final Analysis 4Q19; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Forte Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
TOCA 5 On Track to Readout in 2019; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Forte Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
TOCA 5 Enrollment Completed Ahead of Schedule; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Forte Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
TOCA 5 Fully Enrolled and On Track to Readout in 2019; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Forte Biosciences, Inc.
Industry: Unclassified
TOCA 5 Crosses First Hurdle; Could Complete Enrollment Ahead of Schedule; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Forte Biosciences, Inc.
Industry: Unclassified
TOCA 5 on Track to Interim Results; First Commercial Partner Secured; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Forte Biosciences, Inc.
Industry: Unclassified
A Versatile Viral Delivery Platform Against Cancer; Initiate With Buy and $14.50 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
|